Top Story

Five recent FDA approvals and actions involving allergy, asthma

August 22, 2014

Recent FDA actions have included the approval of fluticasone propionate 50 mcg spray for over-the-counter treatment of hay fever and upper respiratory allergy symptoms, as well as the acceptance of a new drug application for an albuterol multi-dose breath-actuated dry-powder inhaler.

Here are highlights of FDA news presented in Healio Allergy/Immunology:

Patient-centered medical home program decreased hospital use, lowered care costs

August 22, 2014
In the 3 years since its introduction, CareFirst Blue Cross Blue Shield’s Patient-Centered Medical Home model has resulted in reduced hospital utilization, lower…
FDA News

FDA approves combination HIV treatment

August 22, 2014
The FDA today approved a combination treatment for HIV-1 infection, according to a press release.The fixed-dose combination product, to be marketed as Triumeq (ViiV…

Pharmacy shelf cards for probiotics rolled out in effort to aid consumers

August 22, 2014
Sigma-Tau Pharmaceuticals has announced a nationwide rollout of pharmacy shelf cards to better position its VSL#3 probiotics to make them more visible to consumers…
More News Headlines »

Treatment Decision-Making through the Spectrum of MDS: Case 1 Low Risk MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain MDS…
More »
Research Brief

Three-Calendar-Year Bachelor of Science in Nursing: An Innovative Curriculum Program

Journal of Nursing Education
Online Advanced Release, August 20, 2014
The 3-calendar-year Bachelor of Science in Nursing (BSN) curriculum program was developed to facilitate a quicker entry…
More »

A video perspective on the efficacy of stem cell therapy for treating degenerative disc disease

August 21, 2014
At the International Spine Intervention Society Annual Meeting, Wenchun Qu, MD, PhD, of the Mayo Clinic, in Rochester
More »